| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.997 | 0.001 | 0.997 | Apoptosis agonist | 0.362 0.132 DBMET01468 0.993 0.002 DBMET01461 0.969 0.004 DBMET01459 0.885 0.007 DBMET01466 0.989 0.002 DBMET01467 | ||
| 0.497 | 0.027 | 0.563 | GABA C receptor rho-3 antagonist | 0.563 0.012 DBMET01461 0.234 0.169 DBMET01459 0.497 0.027 DBMET01460 0.234 0.169 DBMET01466 0.558 0.013 DBMET01467 | DBMET01461 | |
| 0.472 | 0.006 | 0.584 | Alpha-N-acetylglucosaminidase inhibitor | 0.187 0.038 DBMET01468 0.549 0.004 DBMET01461 0.508 0.005 DBMET01459 0.472 0.006 DBMET01460 0.508 0.005 DBMET01466 0.584 0.004 DBMET01467 | DBMET01467 | |
| 0.365 | 0.006 | 0.5 | GABA C receptor agonist | 0.157 0.031 DBMET01468 0.436 0.004 DBMET01461 0.5 0.004 DBMET01459 0.365 0.006 DBMET01460 0.5 0.004 DBMET01466 0.468 0.004 DBMET01467 | DBMET01466 | |
| 0.431 | 0.075 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.489 0.039 DBMET01461 0.431 0.075 DBMET01460 0.479 0.044 DBMET01467 | DBMET01461 | |
| 0.354 | 0.004 | 0.365 | GABA C receptor antagonist | 0.213 0.01 DBMET01461 0.141 0.035 DBMET01459 0.35 0.004 DBMET01460 0.177 0.019 DBMET01466 0.365 0.004 DBMET01467 | DBMET01467 | |
| 0.33 | 0.032 | 0.749 | Peroxidase inhibitor | 0.749 0.002 DBMET01468 0.414 0.019 DBMET01461 0.497 0.01 DBMET01459 0.33 0.032 DBMET01460 0.497 0.01 DBMET01466 0.439 0.015 DBMET01467 | DBMET01468 | |
| 0.308 | 0.029 | 0.45 | Tyrosine 3 hydroxylase inhibitor | 0.282 0.043 DBMET01468 0.346 0.017 DBMET01461 0.45 0.005 DBMET01459 0.308 0.029 DBMET01460 0.45 0.005 DBMET01466 0.354 0.015 DBMET01467 | DBMET01466 | |
| 0.282 | 0.004 | 0.287 | GABA C receptor rho-1 antagonist | 0.185 0.011 DBMET01461 0.126 0.035 DBMET01459 0.279 0.004 DBMET01460 0.158 0.018 DBMET01466 0.287 0.004 DBMET01467 | DBMET01467 | |
| 0.279 | 0.009 | 0.348 | Ferrochelatase inhibitor | 0.336 0.005 DBMET01461 0.28 0.009 DBMET01459 0.279 0.009 DBMET01460 0.28 0.009 DBMET01466 0.348 0.005 DBMET01467 | DBMET01467 | |
| 0.307 | 0.041 | 0.373 | 5 Hydroxytryptamine uptake stimulant | 0.373 0.02 DBMET01461 0.358 0.023 DBMET01459 0.307 0.041 DBMET01460 0.358 0.023 DBMET01466 0.371 0.02 DBMET01467 | DBMET01461 | |
| 0.315 | 0.065 | 0.459 | 5 Hydroxytryptamine release stimulant | 0.459 0.034 DBMET01461 0.262 0.084 DBMET01459 0.315 0.065 DBMET01460 0.262 0.084 DBMET01466 0.456 0.035 DBMET01467 | DBMET01461 | |
| 0.311 | 0.063 | 0.504 | Aldehyde oxidase inhibitor | 0.462 0.038 DBMET01461 0.218 0.096 DBMET01459 0.311 0.063 DBMET01460 0.218 0.096 DBMET01466 0.504 0.032 DBMET01467 | DBMET01467 | |
| 0.355 | 0.111 | 0.428 | 5 Hydroxytryptamine release inhibitor | 0.42 0.066 DBMET01461 0.336 0.127 DBMET01459 0.355 0.111 DBMET01460 0.336 0.127 DBMET01466 0.428 0.062 DBMET01467 | DBMET01467 | |
| 0.291 | 0.054 | 0.458 | Superoxide dismutase inhibitor | 0.392 0.028 DBMET01468 0.29 0.054 DBMET01461 0.359 0.034 DBMET01459 0.227 0.092 DBMET01460 0.458 0.018 DBMET01466 0.303 0.049 DBMET01467 | DBMET01466 | |
| 0.244 | 0.024 | 0.287 | Succinate dehydrogenase inhibitor | 0.138 0.136 DBMET01468 0.274 0.016 DBMET01461 0.245 0.024 DBMET01459 0.244 0.024 DBMET01460 0.245 0.024 DBMET01466 0.287 0.013 DBMET01467 | DBMET01467 | |
| 0.205 | 0.017 | 0.392 | UDP-glucose 4-epimerase inhibitor | 0.261 0.012 DBMET01461 0.096 0.066 DBMET01459 0.392 0.006 DBMET01460 0.096 0.066 DBMET01466 0.279 0.011 DBMET01467 | DBMET01460 | |
| 0.22 | 0.036 | 0.256 | 5 Hydroxytryptamine 3E antagonist | 0.256 0.014 DBMET01461 0.22 0.036 DBMET01460 0.244 0.019 DBMET01467 | DBMET01461 | |
| 0.229 | 0.05 | 0.26 | Nitric-oxide synthase stimulant | 0.26 0.026 DBMET01461 0.192 0.102 DBMET01459 0.229 0.05 DBMET01460 0.192 0.102 DBMET01466 0.26 0.026 DBMET01467 | DBMET01467 | |
| 0.183 | 0.013 | 0.374 | Triose-phosphate isomerase inhibitor | 0.228 0.008 DBMET01461 0.169 0.015 DBMET01459 0.374 0.004 DBMET01460 0.169 0.015 DBMET01466 0.248 0.007 DBMET01467 | DBMET01460 | |
| 0.186 | 0.017 | 0.327 | Adenylate kinase inhibitor | 0.254 0.01 DBMET01468 0.223 0.012 DBMET01461 0.275 0.008 DBMET01459 0.327 0.005 DBMET01460 0.275 0.008 DBMET01466 0.238 0.011 DBMET01467 | DBMET01460 | |
| 0.173 | 0.01 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.181 0.006 DBMET01461 0.148 0.047 DBMET01459 0.173 0.01 DBMET01460 0.148 0.047 DBMET01466 0.183 0.005 DBMET01467 | DBMET01467 | |
| 0.272 | 0.112 | 0.518 | Transcription factor NF kappa B inhibitor | 0.264 0.118 DBMET01461 0.237 0.137 DBMET01459 0.518 0.042 DBMET01466 0.468 0.049 DBMET01467 | DBMET01466 | |
| 0.191 | 0.034 | 0.23 | GABA C receptor rho-2 antagonist | 0.23 0.016 DBMET01461 0.191 0.034 DBMET01460 0.228 0.017 DBMET01467 | DBMET01461 | |
| 0.169 | 0.014 | 0.336 | NADH dehydrogenase inhibitor | 0.204 0.01 DBMET01461 0.138 0.021 DBMET01459 0.336 0.006 DBMET01460 0.138 0.021 DBMET01466 0.217 0.009 DBMET01467 | DBMET01460 | |
| 0.192 | 0.041 | 0.216 | Arachidonic acid antagonist | 0.204 0.029 DBMET01461 0.138 0.103 DBMET01459 0.216 0.02 DBMET01460 0.138 0.103 DBMET01466 0.207 0.027 DBMET01467 | DBMET01460 | |
| 0.268 | 0.126 | 0.394 | Calcium channel activator | 0.327 0.067 DBMET01461 0.394 0.027 DBMET01460 0.325 0.069 DBMET01467 | DBMET01460 | |
| 0.159 | 0.019 | 0.375 | Porphobilinogen synthase inhibitor | 0.215 0.01 DBMET01461 0.157 0.019 DBMET01459 0.375 0.004 DBMET01460 0.157 0.019 DBMET01466 0.234 0.009 DBMET01467 | DBMET01460 | |
| 0.164 | 0.023 | 0.34 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.265 0.008 DBMET01468 0.21 0.014 DBMET01461 0.284 0.007 DBMET01459 0.34 0.005 DBMET01460 0.284 0.007 DBMET01466 0.224 0.012 DBMET01467 | DBMET01460 | |
| 0.154 | 0.017 | 0.264 | Phosphofructokinase-1 inhibitor | 0.111 0.028 DBMET01468 0.181 0.013 DBMET01461 0.217 0.01 DBMET01459 0.264 0.007 DBMET01460 0.217 0.01 DBMET01466 0.193 0.012 DBMET01467 | DBMET01460 | |
| 0.145 | 0.012 | 0.324 | Carbamoyl phosphate synthetase inhibitor | 0.175 0.009 DBMET01468 0.171 0.009 DBMET01461 0.324 0.004 DBMET01459 0.273 0.005 DBMET01460 0.324 0.004 DBMET01466 0.184 0.008 DBMET01467 | DBMET01466 | |
| 0.143 | 0.011 | 0.246 | Alcohol oxidase inhibitor | 0.21 0.006 DBMET01461 0.168 0.009 DBMET01459 0.143 0.011 DBMET01460 0.168 0.009 DBMET01466 0.246 0.005 DBMET01467 | DBMET01467 | |
| 0.152 | 0.023 | 0.253 | Creatine kinase inhibitor | 0.182 0.014 DBMET01461 0.127 0.036 DBMET01459 0.253 0.005 DBMET01460 0.127 0.036 DBMET01466 0.194 0.012 DBMET01467 | DBMET01460 | |
| 0.212 | 0.083 | 0.372 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 DBMET01461 0.372 0.021 DBMET01460 0.25 0.049 DBMET01467 | DBMET01460 | |
| 0.128 | 0.012 | 0.255 | Biliverdin reductase inhibitor | 0.16 0.008 DBMET01461 0.129 0.012 DBMET01459 0.255 0.004 DBMET01460 0.129 0.012 DBMET01466 0.172 0.007 DBMET01467 | DBMET01460 | |
| 0.161 | 0.046 | 0.201 | Adenylate cyclase stimulant | 0.141 0.079 DBMET01468 0.176 0.029 DBMET01461 0.162 0.044 DBMET01459 0.201 0.013 DBMET01460 0.162 0.044 DBMET01466 0.18 0.026 DBMET01467 | DBMET01460 | |
| 0.124 | 0.012 | 0.218 | Acyl-CoA dehydrogenase inhibitor | 0.082 0.022 DBMET01468 0.159 0.008 DBMET01461 0.097 0.017 DBMET01459 0.218 0.004 DBMET01460 0.097 0.017 DBMET01466 0.166 0.008 DBMET01467 | DBMET01460 | |
| 0.301 | 0.193 | 0.449 | Caspase 9 stimulant | 0.38 0.123 DBMET01461 0.449 0.084 DBMET01460 0.385 0.12 DBMET01467 | DBMET01460 | |
| 0.137 | 0.029 | 0.191 | DOPA decarboxylase inhibitor | 0.153 0.02 DBMET01461 0.191 0.008 DBMET01459 0.189 0.009 DBMET01460 0.191 0.008 DBMET01466 0.159 0.017 DBMET01467 | DBMET01466 | |
| 0.122 | 0.022 | 0.432 | Glutamate dehydrogenase inhibitor | 0.432 0.004 DBMET01468 0.149 0.016 DBMET01461 0.338 0.005 DBMET01459 0.244 0.007 DBMET01460 0.338 0.005 DBMET01466 0.161 0.014 DBMET01467 | DBMET01468 | |
| 0.142 | 0.044 | 0.215 | Cystathionine beta-synthase inhibitor | 0.178 0.03 DBMET01461 0.215 0.021 DBMET01459 0.142 0.044 DBMET01460 0.215 0.021 DBMET01466 0.192 0.026 DBMET01467 | DBMET01466 | |
| 0.116 | 0.022 | 0.828 | Glutamate decarboxylase inhibitor | 0.828 0.002 DBMET01468 0.14 0.015 DBMET01461 0.29 0.004 DBMET01459 0.194 0.007 DBMET01460 0.29 0.004 DBMET01466 0.151 0.013 DBMET01467 | DBMET01468 | |
| 0.103 | 0.014 | 0.211 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.127 0.01 DBMET01461 0.063 0.032 DBMET01459 0.211 0.006 DBMET01460 0.063 0.032 DBMET01466 0.135 0.01 DBMET01467 | DBMET01460 | |
| 0.204 | 0.117 | 0.324 | DNA synthesis inhibitor | 0.202 0.12 DBMET01468 0.235 0.078 DBMET01461 0.249 0.067 DBMET01459 0.324 0.036 DBMET01460 0.249 0.067 DBMET01466 0.244 0.071 DBMET01467 | DBMET01460 | |
| 0.096 | 0.009 | 0.13 | Aconitate hydratase inhibitor | 0.118 0.006 DBMET01461 0.103 0.008 DBMET01459 0.096 0.009 DBMET01460 0.103 0.008 DBMET01466 0.13 0.005 DBMET01467 | DBMET01467 | |
| 0.132 | 0.046 | 0.516 | Aminopeptidase B inhibitor | 0.516 0.003 DBMET01468 0.155 0.036 DBMET01461 0.236 0.015 DBMET01459 0.201 0.021 DBMET01460 0.236 0.015 DBMET01466 0.162 0.033 DBMET01467 | DBMET01468 | |
| 0.089 | 0.007 | 0.139 | Glucose-6-phosphate isomerase inhibitor | 0.1 0.005 DBMET01461 0.069 0.013 DBMET01459 0.139 0.003 DBMET01460 0.069 0.013 DBMET01466 0.106 0.004 DBMET01467 | DBMET01460 | |
| 0.12 | 0.04 | 0.148 | Anabolic | 0.112 0.048 DBMET01468 0.133 0.029 DBMET01461 0.096 0.069 DBMET01459 0.148 0.019 DBMET01460 0.096 0.069 DBMET01466 0.136 0.026 DBMET01467 | DBMET01460 | |
| 0.102 | 0.027 | 0.287 | Aminopeptidase I inhibitor | 0.287 0.003 DBMET01468 0.118 0.02 DBMET01461 0.187 0.008 DBMET01459 0.166 0.01 DBMET01460 0.187 0.008 DBMET01466 0.124 0.018 DBMET01467 | DBMET01468 | |
| 0.096 | 0.02 | 0.276 | Argininosuccinate synthase inhibitor | 0.113 0.016 DBMET01468 0.127 0.014 DBMET01461 0.276 0.004 DBMET01459 0.212 0.007 DBMET01460 0.276 0.004 DBMET01466 0.138 0.013 DBMET01467 | DBMET01466 | |
| 0.104 | 0.029 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | 0.122 0.015 DBMET01461 0.088 0.056 DBMET01459 0.104 0.029 DBMET01460 0.088 0.056 DBMET01466 0.121 0.015 DBMET01467 | DBMET01461 | |
| 0.173 | 0.103 | 0.285 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.212 0.063 DBMET01461 0.285 0.029 DBMET01460 0.22 0.058 DBMET01467 | DBMET01460 | |
| 0.086 | 0.019 | 0.163 | Glutamate (mGluR6) antagonist | 0.077 0.027 DBMET01468 0.096 0.012 DBMET01461 0.163 0.003 DBMET01459 0.134 0.004 DBMET01460 0.163 0.003 DBMET01466 0.1 0.01 DBMET01467 | DBMET01466 | |
| 0.11 | 0.045 | 0.142 | Electrolyte absorption antagonist | 0.139 0.024 DBMET01461 0.11 0.045 DBMET01460 0.142 0.023 DBMET01467 | DBMET01467 | |
| 0.093 | 0.029 | 0.281 | Phenylalanine 4-hydroxylase inhibitor | 0.117 0.019 DBMET01468 0.12 0.018 DBMET01461 0.281 0.004 DBMET01459 0.093 0.029 DBMET01460 0.281 0.004 DBMET01466 0.133 0.015 DBMET01467 | DBMET01466 | |
| 0.093 | 0.035 | 0.105 | Estrogen-related receptor beta agonist | 0.101 0.023 DBMET01461 0.093 0.035 DBMET01460 0.105 0.02 DBMET01467 | DBMET01467 | |
| 0.204 | 0.15 | 0.4 | Insulysin inhibitor | 0.4 0.022 DBMET01468 0.247 0.099 DBMET01461 0.273 0.077 DBMET01459 0.204 0.15 DBMET01460 0.273 0.077 DBMET01466 0.252 0.095 DBMET01467 | DBMET01468 | |
| 0.084 | 0.03 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.097 0.015 DBMET01461 0.07 0.059 DBMET01459 0.084 0.03 DBMET01460 0.07 0.059 DBMET01466 0.096 0.016 DBMET01467 | DBMET01461 | |
| 0.104 | 0.051 | 0.135 | Prolactin inhibitor | 0.132 0.031 DBMET01461 0.11 0.046 DBMET01459 0.104 0.051 DBMET01460 0.11 0.046 DBMET01466 0.135 0.029 DBMET01467 | DBMET01467 | |
| 0.077 | 0.027 | 0.152 | Purinergic P2X1 antagonist | 0.096 0.018 DBMET01461 0.152 0.007 DBMET01460 0.102 0.016 DBMET01467 | DBMET01460 | |
| 0.113 | 0.062 | 0.167 | 5 Hydroxytryptamine 3A agonist | 0.167 0.027 DBMET01461 0.113 0.062 DBMET01460 0.156 0.032 DBMET01467 | DBMET01461 | |
| 0.091 | 0.042 | 0.131 | D-Ala-D-Ala ligase inhibitor | 0.101 0.028 DBMET01461 0.131 0.009 DBMET01460 0.104 0.024 DBMET01467 | DBMET01460 | |
| 0.083 | 0.035 | 0.116 | Glycine receptor agonist | 0.1 0.021 DBMET01461 0.116 0.014 DBMET01459 0.083 0.035 DBMET01460 0.116 0.014 DBMET01466 0.104 0.019 DBMET01467 | DBMET01466 | |
| 0.14 | 0.092 | 0.163 | Interferon gamma antagonist | 0.158 0.068 DBMET01461 0.135 0.101 DBMET01459 0.14 0.092 DBMET01460 0.135 0.101 DBMET01466 0.163 0.063 DBMET01467 | DBMET01467 | |
| 0.131 | 0.084 | 0.248 | Mannose-6-phosphate isomerase inhibitor | 0.175 0.046 DBMET01461 0.248 0.012 DBMET01460 0.178 0.043 DBMET01467 | DBMET01460 | |
| 0.077 | 0.031 | 0.098 | Glutamate (mGluR7) antagonist | 0.094 0.014 DBMET01461 0.098 0.012 DBMET01459 0.077 0.031 DBMET01460 0.098 0.012 DBMET01466 0.094 0.014 DBMET01467 | DBMET01466 | |
| 0.071 | 0.025 | 0.337 | Ornithine carbamoyltransferase inhibitor | 0.337 0.004 DBMET01468 0.086 0.019 DBMET01461 0.217 0.006 DBMET01459 0.142 0.01 DBMET01460 0.217 0.006 DBMET01466 0.094 0.017 DBMET01467 | DBMET01468 | |
| 0.085 | 0.039 | 0.59 | Histidine decarboxylase inhibitor | 0.59 0.002 DBMET01468 0.121 0.025 DBMET01461 0.319 0.005 DBMET01459 0.214 0.012 DBMET01460 0.319 0.005 DBMET01466 0.137 0.022 DBMET01467 | DBMET01468 | |
| 0.057 | 0.013 | 0.074 | Dopamine D5 agonist | 0.069 0.009 DBMET01461 0.057 0.013 DBMET01460 0.074 0.007 DBMET01467 | DBMET01467 | |
| 0.054 | 0.012 | 0.129 | Fumarate hydratase inhibitor | 0.068 0.009 DBMET01461 0.126 0.004 DBMET01459 0.129 0.004 DBMET01460 0.126 0.004 DBMET01466 0.076 0.007 DBMET01467 | DBMET01460 | |
| 0.053 | 0.012 | 0.064 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.06 0.007 DBMET01461 0.049 0.016 DBMET01459 0.053 0.012 DBMET01460 0.049 0.016 DBMET01466 0.064 0.006 DBMET01467 | DBMET01467 | |
| 0.086 | 0.045 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.096 0.035 DBMET01461 0.089 0.042 DBMET01460 0.098 0.033 DBMET01467 | DBMET01467 | |
| 0.081 | 0.039 | 0.094 | Vanilloid 4 agonist | 0.094 0.021 DBMET01461 0.081 0.039 DBMET01460 0.093 0.023 DBMET01467 | DBMET01461 | |
| 0.052 | 0.011 | 0.112 | Glutamate (mGluR8) agonist | 0.052 0.01 DBMET01468 0.059 0.007 DBMET01461 0.112 0.003 DBMET01459 0.09 0.003 DBMET01460 0.112 0.003 DBMET01466 0.062 0.006 DBMET01467 | DBMET01466 | |
| 0.063 | 0.023 | 0.076 | Alpha-mannosidase inhibitor | 0.072 0.015 DBMET01461 0.073 0.014 DBMET01459 0.071 0.016 DBMET01460 0.073 0.014 DBMET01466 0.076 0.013 DBMET01467 | DBMET01467 | |
| 0.073 | 0.036 | 0.094 | Exportin-1 inhibitor | 0.094 0.012 DBMET01461 0.073 0.036 DBMET01460 0.089 0.016 DBMET01467 | DBMET01461 | |
| 0.085 | 0.049 | 0.127 | Glycine receptor antagonist | 0.105 0.028 DBMET01461 0.127 0.014 DBMET01460 0.108 0.026 DBMET01467 | DBMET01460 | |
| 0.05 | 0.014 | 0.108 | Kainate receptor agonist | 0.046 0.019 DBMET01468 0.056 0.009 DBMET01461 0.108 0.003 DBMET01459 0.05 0.014 DBMET01460 0.108 0.003 DBMET01466 0.059 0.007 DBMET01467 | DBMET01466 | |
| 0.16 | 0.124 | 0.201 | Neurotrophic factor enhancer | 0.196 0.081 DBMET01461 0.183 0.094 DBMET01460 0.201 0.076 DBMET01467 | DBMET01467 | |
| 0.199 | 0.166 | 0.279 | Cholesterol antagonist | 0.264 0.115 DBMET01461 0.189 0.175 DBMET01459 0.243 0.13 DBMET01460 0.189 0.175 DBMET01466 0.279 0.105 DBMET01467 | DBMET01467 | |
| 0.052 | 0.019 | 0.071 | Guanylate cyclase inhibitor | 0.06 0.011 DBMET01461 0.071 0.004 DBMET01460 0.062 0.01 DBMET01467 | DBMET01460 | |
| 0.091 | 0.059 | 0.113 | Glutamate release inhibitor | 0.113 0.027 DBMET01461 0.091 0.059 DBMET01460 0.112 0.028 DBMET01467 | DBMET01461 | |
| 0.037 | 0.009 | 0.042 | Purinergic P2Y15 antagonist | 0.041 0.006 DBMET01461 0.037 0.009 DBMET01460 0.042 0.006 DBMET01467 | DBMET01467 | |
| 0.078 | 0.051 | 0.088 | MAP kinase kinase 7 inhibitor | 0.086 0.031 DBMET01461 0.078 0.051 DBMET01460 0.088 0.027 DBMET01467 | DBMET01467 | |
| 0.145 | 0.117 | 0.51 | Phospholipase C inhibitor | 0.51 0.005 DBMET01468 0.166 0.079 DBMET01461 0.198 0.045 DBMET01459 0.242 0.027 DBMET01460 0.198 0.045 DBMET01466 0.172 0.07 DBMET01467 | DBMET01468 | |
| 0.059 | 0.033 | 0.068 | Pregnane X receptor antagonist | 0.068 0.017 DBMET01461 0.059 0.033 DBMET01460 0.068 0.016 DBMET01467 | DBMET01467 | |
| 0.05 | 0.025 | 0.064 | Mannosidase inhibitor | 0.06 0.017 DBMET01461 0.061 0.016 DBMET01459 0.058 0.018 DBMET01460 0.061 0.016 DBMET01466 0.064 0.014 DBMET01467 | DBMET01467 | |
| 0.073 | 0.048 | 0.09 | Phospholipase D inhibitor | 0.089 0.023 DBMET01461 0.09 0.022 DBMET01460 0.088 0.024 DBMET01467 | DBMET01460 | |
| 0.105 | 0.08 | 0.129 | Photosensitizer | 0.127 0.049 DBMET01461 0.104 0.081 DBMET01459 0.105 0.08 DBMET01460 0.104 0.081 DBMET01466 0.129 0.047 DBMET01467 | DBMET01467 | |
| 0.134 | 0.109 | 0.162 | CF transmembrane conductance regulator agonist | 0.16 0.06 DBMET01461 0.134 0.109 DBMET01460 0.162 0.058 DBMET01467 | DBMET01467 | |
| 0.089 | 0.066 | 0.127 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 DBMET01461 0.088 0.067 DBMET01459 0.089 0.066 DBMET01460 0.088 0.067 DBMET01466 0.127 0.035 DBMET01467 | DBMET01467 | |
| 0.212 | 0.189 | 0.437 | Histamine release inhibitor | 0.437 0.056 DBMET01468 0.299 0.124 DBMET01461 0.223 0.178 DBMET01459 0.414 0.069 DBMET01460 0.223 0.178 DBMET01466 0.319 0.114 DBMET01467 | DBMET01468 | |
| 0.057 | 0.034 | 0.069 | Dihydroorotate oxidase inhibitor | 0.066 0.021 DBMET01461 0.057 0.034 DBMET01460 0.069 0.018 DBMET01467 | DBMET01467 | |
| 0.17 | 0.149 | 0.34 | Interleukin agonist | 0.34 0.032 DBMET01468 0.229 0.095 DBMET01461 0.279 0.06 DBMET01459 0.272 0.064 DBMET01460 0.279 0.06 DBMET01466 0.234 0.091 DBMET01467 | DBMET01468 | |
| 0.073 | 0.052 | 0.309 | Catalase inhibitor | 0.309 0.005 DBMET01468 0.109 0.036 DBMET01461 0.219 0.012 DBMET01459 0.093 0.041 DBMET01460 0.219 0.012 DBMET01466 0.125 0.032 DBMET01467 | DBMET01468 | |
| 0.034 | 0.015 | 0.064 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.042 0.011 DBMET01461 0.064 0.006 DBMET01460 0.044 0.011 DBMET01467 | DBMET01460 | |
| 0.109 | 0.09 | 0.142 | Cathepsin H inhibitor | 0.124 0.07 DBMET01468 0.142 0.053 DBMET01461 0.137 0.057 DBMET01459 0.109 0.09 DBMET01460 0.137 0.057 DBMET01466 0.139 0.055 DBMET01467 | DBMET01461 | |
| 0.139 | 0.121 | 0.139 | ATPase inhibitor | 0.137 0.125 DBMET01461 0.139 0.122 DBMET01467 | ||
| 0.029 | 0.012 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DBMET01461 0.024 0.02 DBMET01459 0.033 0.007 DBMET01460 0.024 0.02 DBMET01466 0.033 0.007 DBMET01467 | DBMET01467 | |
| 0.073 | 0.058 | 0.123 | GABA B receptor agonist | 0.085 0.033 DBMET01461 0.08 0.042 DBMET01459 0.123 0.007 DBMET01460 0.08 0.042 DBMET01466 0.088 0.028 DBMET01467 | DBMET01460 | |
| 0.093 | 0.078 | 0.121 | Carbonic anhydrase XV inhibitor | 0.118 0.048 DBMET01461 0.093 0.078 DBMET01460 0.121 0.046 DBMET01467 | DBMET01467 | |
| 0.021 | 0.007 | 0.028 | Carbonic anhydrase VIII inhibitor | 0.028 0.005 DBMET01461 0.017 0.011 DBMET01459 0.021 0.007 DBMET01460 0.017 0.011 DBMET01466 0.028 0.005 DBMET01467 | DBMET01467 | |
| 0.021 | 0.007 | 0.028 | Carbonic anhydrase X inhibitor | 0.028 0.005 DBMET01461 0.017 0.011 DBMET01459 0.021 0.007 DBMET01460 0.017 0.011 DBMET01466 0.028 0.005 DBMET01467 | DBMET01467 | |
| 0.046 | 0.032 | 0.066 | Adenylate cyclase 1 inhibitor | 0.065 0.014 DBMET01461 0.046 0.032 DBMET01460 0.066 0.014 DBMET01467 | DBMET01467 | |
| 0.04 | 0.026 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.061 0.01 DBMET01461 0.04 0.026 DBMET01460 0.058 0.012 DBMET01467 | DBMET01461 | |
| 0.02 | 0.007 | 0.023 | Telomerase stimulant | 0.023 0.005 DBMET01461 0.021 0.007 DBMET01459 0.02 0.007 DBMET01460 0.021 0.007 DBMET01466 0.023 0.005 DBMET01467 | DBMET01467 | |
| 0.039 | 0.027 | 0.087 | Membrane dipeptidase inhibitor | 0.087 0.004 DBMET01468 0.045 0.02 DBMET01461 0.06 0.01 DBMET01459 0.066 0.008 DBMET01460 0.06 0.01 DBMET01466 0.048 0.018 DBMET01467 | DBMET01468 | |
| 0.049 | 0.037 | 0.084 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET01468 0.057 0.026 DBMET01461 0.048 0.038 DBMET01459 0.084 0.008 DBMET01460 0.048 0.038 DBMET01466 0.06 0.022 DBMET01467 | DBMET01460 | |
| 0.054 | 0.042 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.06 0.024 DBMET01461 0.054 0.042 DBMET01460 0.061 0.022 DBMET01467 | DBMET01467 | |
| 0.02 | 0.009 | 0.026 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET01461 0.026 0.004 DBMET01460 0.021 0.007 DBMET01467 | DBMET01460 | |
| 0.032 | 0.023 | 0.054 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET01468 0.036 0.015 DBMET01461 0.054 0.004 DBMET01459 0.042 0.008 DBMET01460 0.054 0.004 DBMET01466 0.037 0.013 DBMET01467 | DBMET01466 | |
| 0.025 | 0.017 | 0.044 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET01468 0.029 0.012 DBMET01461 0.044 0.005 DBMET01460 0.03 0.011 DBMET01467 | DBMET01460 | |
| 0.027 | 0.019 | 0.031 | Hedgehog signaling activator | 0.031 0.011 DBMET01461 0.027 0.019 DBMET01460 0.031 0.01 DBMET01467 | DBMET01467 | |
| 0.078 | 0.071 | 0.09 | CC chemokine 5 receptor agonist | 0.09 0.037 DBMET01461 0.078 0.071 DBMET01460 0.089 0.038 DBMET01467 | DBMET01461 | |
| 0.094 | 0.087 | 0.223 | Mucolytic | 0.223 0.009 DBMET01468 0.115 0.059 DBMET01461 0.163 0.026 DBMET01459 0.152 0.031 DBMET01460 0.163 0.026 DBMET01466 0.121 0.053 DBMET01467 | DBMET01468 | |
| 0.069 | 0.063 | 0.106 | GABA aminotransferase inhibitor | 0.086 0.039 DBMET01461 0.106 0.023 DBMET01459 0.069 0.063 DBMET01460 0.106 0.023 DBMET01466 0.09 0.035 DBMET01467 | DBMET01466 | |
| 0.041 | 0.035 | 0.079 | Geranyltranstransferase inhibitor | 0.052 0.021 DBMET01461 0.079 0.005 DBMET01460 0.056 0.017 DBMET01467 | DBMET01460 | |
| 0.039 | 0.033 | 0.06 | Oxytocin agonist | 0.06 0.017 DBMET01468 0.048 0.025 DBMET01461 0.039 0.033 DBMET01460 0.049 0.025 DBMET01467 | DBMET01468 | |
| 0.028 | 0.022 | 0.033 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET01461 0.028 0.022 DBMET01460 0.033 0.012 DBMET01467 | DBMET01467 | |
| 0.041 | 0.036 | 0.052 | Histamine H1 receptor agonist | 0.052 0.015 DBMET01461 0.041 0.036 DBMET01460 0.049 0.02 DBMET01467 | DBMET01461 | |
| 0.126 | 0.121 | 0.158 | Melanin inhibitor | 0.143 0.092 DBMET01461 0.158 0.072 DBMET01460 0.148 0.084 DBMET01467 | DBMET01460 | |
| 0.138 | 0.133 | 0.235 | Neurotensin receptor agonist | 0.235 0.024 DBMET01468 0.157 0.086 DBMET01461 0.191 0.04 DBMET01459 0.138 0.133 DBMET01460 0.191 0.04 DBMET01466 0.159 0.082 DBMET01467 | DBMET01468 | |
| 0.07 | 0.065 | 0.108 | Keratolytic | 0.083 0.045 DBMET01461 0.078 0.052 DBMET01459 0.108 0.026 DBMET01460 0.078 0.052 DBMET01466 0.088 0.04 DBMET01467 | DBMET01460 | |
| 0.014 | 0.009 | 0.034 | Lysophosphatidic acid receptor 3 agonist | 0.017 0.006 DBMET01461 0.034 0.003 DBMET01460 0.019 0.006 DBMET01467 | DBMET01460 | |
| 0.016 | 0.011 | 0.024 | Purinergic P2Y1 agonist | 0.017 0.009 DBMET01461 0.016 0.01 DBMET01459 0.024 0.005 DBMET01460 0.016 0.01 DBMET01466 0.018 0.008 DBMET01467 | DBMET01460 | |
| 0.098 | 0.094 | 0.119 | Microtubule formation inhibitor | 0.116 0.066 DBMET01461 0.119 0.062 DBMET01460 0.118 0.062 DBMET01467 | DBMET01460 | |
| 0.046 | 0.041 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 DBMET01461 0.046 0.041 DBMET01460 0.056 0.019 DBMET01467 | DBMET01467 | |
| 0.013 | 0.01 | 0.027 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 DBMET01461 0.027 0.003 DBMET01460 0.016 0.005 DBMET01467 | DBMET01460 | |
| 0.055 | 0.053 | 0.064 | Ryanodine receptor antagonist | 0.064 0.028 DBMET01461 0.061 0.036 DBMET01460 0.064 0.027 DBMET01467 | DBMET01467 | |
| 0.122 | 0.12 | 0.194 | Sphingosine 1-phosphate receptor 5 antagonist | 0.145 0.071 DBMET01461 0.124 0.115 DBMET01459 0.194 0.014 DBMET01460 0.124 0.115 DBMET01466 0.15 0.062 DBMET01467 | DBMET01460 | |
| 0.048 | 0.046 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.03 DBMET01461 0.048 0.046 DBMET01460 0.064 0.026 DBMET01467 | DBMET01467 | |
| 0.011 | 0.009 | 0.043 | Glutamate (mGluR6) agonist | 0.012 0.009 DBMET01468 0.014 0.007 DBMET01461 0.043 0.002 DBMET01459 0.027 0.003 DBMET01460 0.043 0.002 DBMET01466 0.015 0.006 DBMET01467 | DBMET01466 | |
| 0.025 | 0.023 | 0.05 | Uridine phosphorylase inhibitor | 0.035 0.014 DBMET01461 0.05 0.008 DBMET01460 0.038 0.013 DBMET01467 | DBMET01460 | |
| 0.02 | 0.019 | 0.069 | Glutamate (mGluR1a) agonist | 0.022 0.015 DBMET01468 0.029 0.009 DBMET01461 0.069 0.004 DBMET01459 0.02 0.019 DBMET01460 0.069 0.004 DBMET01466 0.03 0.009 DBMET01467 | DBMET01466 | |
| 0.035 | 0.035 | 0.068 | GABA uptake inhibitor | 0.043 0.022 DBMET01461 0.068 0.008 DBMET01460 0.046 0.019 DBMET01467 | DBMET01460 | |
| 0.014 | 0.014 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET01461 0.017 0.008 DBMET01467 | DBMET01467 | |
| 0.038 | 0.038 | 0.056 | Histamine H2 receptor agonist | 0.056 0.017 DBMET01461 0.05 0.022 DBMET01467 | DBMET01461 | |
| 0.024 | 0.024 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DBMET01461 0.028 0.012 DBMET01467 | DBMET01461 | |
| 0.088 | 0.089 | 0.142 | Glutamate (mGluR7) agonist | 0.109 0.043 DBMET01461 0.103 0.054 DBMET01459 0.142 0.015 DBMET01460 0.103 0.054 DBMET01466 0.106 0.048 DBMET01467 | DBMET01460 | |
| 0.038 | 0.04 | 0.048 | Nerve growth factor antagonist | 0.048 0.021 DBMET01461 0.048 0.021 DBMET01467 | DBMET01467 | |
| 0.083 | 0.085 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 DBMET01461 0.111 0.041 DBMET01460 0.11 0.041 DBMET01467 | DBMET01460 | |
| 0.017 | 0.02 | 0.02 | Antibiotic Anthracycline-like | 0.019 0.013 DBMET01461 0.02 0.012 DBMET01467 | DBMET01467 | |
| 0.076 | 0.079 | 0.092 | mTOR complex 2 inhibitor | 0.092 0.044 DBMET01461 0.091 0.045 DBMET01467 | DBMET01461 | |
| 0.128 | 0.131 | 0.161 | Heat shock protein 70 antagonist | 0.141 0.072 DBMET01461 0.129 0.126 DBMET01459 0.161 0.027 DBMET01460 0.129 0.126 DBMET01466 0.142 0.068 DBMET01467 | DBMET01460 | |
| 0.058 | 0.061 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.035 DBMET01461 0.066 0.038 DBMET01467 | DBMET01461 | |
| 0.023 | 0.026 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 DBMET01461 0.031 0.012 DBMET01467 | DBMET01467 | |
| 0.006 | 0.009 | 0.008 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET01461 0.008 0.005 DBMET01467 | DBMET01467 | |
| 0.022 | 0.026 | 0.118 | Lysine carboxypeptidase inhibitor | 0.118 0.003 DBMET01468 0.026 0.019 DBMET01461 0.057 0.006 DBMET01459 0.057 0.006 DBMET01466 0.028 0.017 DBMET01467 | DBMET01468 | |
| 0.018 | 0.023 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET01461 0.022 0.013 DBMET01467 | DBMET01467 | |
| 0.01 | 0.015 | 0.014 | Carbonic anhydrase XI inhibitor | 0.014 0.008 DBMET01461 0.013 0.008 DBMET01467 | DBMET01461 | |
| 0.018 | 0.023 | 0.021 | Retinoid X beta receptor antagonist | 0.02 0.015 DBMET01461 0.021 0.013 DBMET01467 | DBMET01467 | |
| 0.028 | 0.033 | 0.111 | Arginase inhibitor | 0.111 0.003 DBMET01468 0.038 0.024 DBMET01461 0.074 0.007 DBMET01459 0.074 0.007 DBMET01466 0.042 0.021 DBMET01467 | DBMET01468 | |
| 0.008 | 0.013 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET01460 | DBMET01460 | |
| 0.112 | 0.118 | 0.181 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.069 DBMET01461 0.181 0.014 DBMET01460 0.136 0.062 DBMET01467 | DBMET01460 | |
| 0.019 | 0.026 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET01461 0.022 0.018 DBMET01459 0.022 0.018 DBMET01466 0.023 0.015 DBMET01467 | DBMET01467 | |
| 0.024 | 0.031 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET01461 0.033 0.016 DBMET01467 | DBMET01461 | |
| 0.092 | 0.099 | 0.169 | Cholesterol synthesis inhibitor | 0.112 0.073 DBMET01461 0.169 0.036 DBMET01460 0.117 0.068 DBMET01467 | DBMET01460 | |
| 0.039 | 0.046 | 0.045 | Heme oxygenase inhibitor | 0.045 0.023 DBMET01461 0.044 0.024 DBMET01467 | DBMET01461 | |
| 0.018 | 0.025 | 0.022 | Prostaglandin F2 alpha agonist | 0.021 0.018 DBMET01461 0.022 0.016 DBMET01467 | DBMET01467 | |
| 0.176 | 0.184 | 0.253 | Gastrin inhibitor | 0.253 0.076 DBMET01468 0.229 0.107 DBMET01461 0.23 0.105 DBMET01467 | DBMET01468 | |
| 0.071 | 0.079 | 0.105 | Histamine N-methyltransferase inhibitor | 0.105 0.041 DBMET01461 0.102 0.044 DBMET01467 | DBMET01461 | |
| 0.023 | 0.033 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET01461 0.027 0.017 DBMET01460 0.027 0.018 DBMET01467 | DBMET01467 | |
| 0.036 | 0.046 | 0.053 | Adenosine deaminase inhibitor | 0.042 0.039 DBMET01468 0.048 0.032 DBMET01461 0.053 0.027 DBMET01460 0.052 0.028 DBMET01467 | DBMET01460 | |
| 0.098 | 0.108 | 0.257 | Toll-Like receptor 2 antagonist | 0.257 0.008 DBMET01468 0.12 0.077 DBMET01461 0.141 0.059 DBMET01459 0.187 0.03 DBMET01460 0.141 0.059 DBMET01466 0.128 0.07 DBMET01467 | DBMET01468 | |
| 0.043 | 0.053 | 0.053 | Squalene epoxidase inhibitor | 0.053 0.029 DBMET01461 0.052 0.03 DBMET01467 | DBMET01461 | |
| 0.036 | 0.047 | 0.063 | AICAR transformylase inhibitor | 0.054 0.018 DBMET01468 0.043 0.032 DBMET01461 0.048 0.024 DBMET01459 0.063 0.012 DBMET01460 0.048 0.024 DBMET01466 0.045 0.029 DBMET01467 | DBMET01460 | |
| 0.022 | 0.033 | 0.037 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET01461 0.037 0.007 DBMET01460 0.026 0.018 DBMET01467 | DBMET01460 | |
| 0.027 | 0.038 | 0.066 | Phosphoglycerate kinase inhibitor | 0.034 0.025 DBMET01461 0.066 0.01 DBMET01460 0.036 0.023 DBMET01467 | DBMET01460 | |
| 0.013 | 0.024 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET01461 0.017 0.013 DBMET01467 | DBMET01467 | |
| 0.069 | 0.081 | 0.142 | I kappa B kinase inhibitor | 0.142 0.018 DBMET01467 | DBMET01467 | |
| 0.017 | 0.03 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 DBMET01461 0.021 0.015 DBMET01467 | DBMET01467 | |
| 0.077 | 0.091 | 0.161 | Sphingomyelinase inhibitor | 0.099 0.061 DBMET01461 0.161 0.02 DBMET01460 0.105 0.055 DBMET01467 | DBMET01460 | |
| 0.011 | 0.025 | 0.067 | Aminopeptidase A inhibitor | 0.067 0.003 DBMET01468 0.024 0.008 DBMET01459 0.018 0.012 DBMET01460 0.024 0.008 DBMET01466 | DBMET01468 | |
| 0.023 | 0.039 | 0.068 | Calcitonin receptor agonist | 0.068 0.013 DBMET01468 0.034 0.023 DBMET01459 0.034 0.023 DBMET01466 | DBMET01468 | |
| 0.033 | 0.049 | 0.056 | Thymidine kinase inhibitor | 0.039 0.031 DBMET01461 0.056 0.015 DBMET01460 0.041 0.029 DBMET01467 | DBMET01460 | |
| 0.007 | 0.026 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.007 DBMET01460 | DBMET01460 | |
| 0.046 | 0.064 | 0.134 | Carbonic anhydrase stimulant | 0.134 0.012 DBMET01468 0.058 0.043 DBMET01461 0.086 0.023 DBMET01459 0.086 0.023 DBMET01466 0.059 0.041 DBMET01467 | DBMET01468 | |
| 0.028 | 0.047 | 0.241 | Toll-Like receptor 2 agonist | 0.241 0.005 DBMET01468 0.129 0.012 DBMET01459 0.051 0.023 DBMET01460 0.129 0.012 DBMET01466 | DBMET01468 | |
| 0.078 | 0.097 | 0.106 | Carbonic anhydrase III inhibitor | 0.1 0.061 DBMET01461 0.106 0.055 DBMET01467 | DBMET01467 | |
| 0.094 | 0.113 | 0.157 | Cyclooxygenase 3 inhibitor | 0.129 0.068 DBMET01468 0.125 0.072 DBMET01461 0.105 0.096 DBMET01459 0.157 0.042 DBMET01460 0.105 0.096 DBMET01466 0.126 0.071 DBMET01467 | DBMET01460 | |
| 0.045 | 0.065 | 0.101 | NMDA receptor glycine site agonist | 0.064 0.041 DBMET01461 0.086 0.025 DBMET01459 0.101 0.016 DBMET01460 0.086 0.025 DBMET01466 0.07 0.036 DBMET01467 | DBMET01460 | |
| 0.026 | 0.047 | 0.032 | Retinoid X alpha receptor antagonist | 0.032 0.027 DBMET01467 | DBMET01467 | |
| 0.052 | 0.073 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | 0.082 0.025 DBMET01468 0.066 0.042 DBMET01461 0.063 0.047 DBMET01467 | DBMET01468 | |
| 0.028 | 0.05 | 0.039 | Dihydropteroate synthase inhibitor | 0.038 0.03 DBMET01461 0.039 0.029 DBMET01467 | DBMET01467 | |
| 0.056 | 0.079 | 0.065 | Calcium channel P-type blocker | 0.065 0.04 DBMET01461 0.064 0.041 DBMET01467 | DBMET01461 | |
| 0.029 | 0.052 | 0.036 | Retinoid X receptor antagonist | 0.036 0.03 DBMET01467 | DBMET01467 | |
| 0.105 | 0.129 | 0.17 | Vanilloid 1 agonist | 0.17 0.023 DBMET01468 0.12 0.088 DBMET01461 0.132 0.063 DBMET01460 0.122 0.083 DBMET01467 | DBMET01468 | |
| 0.043 | 0.067 | 0.06 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET01461 0.06 0.031 DBMET01460 0.057 0.036 DBMET01467 | DBMET01460 | |
| 0.018 | 0.043 | 0.042 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET01461 0.042 0.005 DBMET01459 0.042 0.005 DBMET01466 0.023 0.02 DBMET01467 | DBMET01466 | |
| 0.052 | 0.078 | 0.064 | Interferon inducer | 0.062 0.048 DBMET01461 0.064 0.045 DBMET01467 | DBMET01467 | |
| 0.048 | 0.074 | 0.139 | NMDA receptor agonist | 0.139 0.01 DBMET01468 0.06 0.047 DBMET01461 0.138 0.01 DBMET01459 0.094 0.022 DBMET01460 0.138 0.01 DBMET01466 0.065 0.041 DBMET01467 | DBMET01468 | |
| 0.026 | 0.052 | 0.072 | Glutamate (mGluR3) antagonist | 0.034 0.031 DBMET01461 0.072 0.006 DBMET01459 0.047 0.014 DBMET01460 0.072 0.006 DBMET01466 0.036 0.026 DBMET01467 | DBMET01466 | |
| 0.031 | 0.058 | 0.046 | Vanilloid 3 antagonist | 0.038 0.028 DBMET01461 0.046 0.012 DBMET01460 0.038 0.028 DBMET01467 | DBMET01460 | |
| 0.019 | 0.046 | 0.031 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 DBMET01461 | DBMET01461 | |
| 0.121 | 0.148 | 0.275 | Anesthetic general | 0.182 0.086 DBMET01461 0.275 0.04 DBMET01460 0.192 0.079 DBMET01467 | DBMET01460 | |
| 0.017 | 0.045 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.018 DBMET01461 0.027 0.022 DBMET01467 | DBMET01461 | |
| 0.056 | 0.085 | 0.094 | CYP2A6 inhibitor | 0.094 0.039 DBMET01461 0.083 0.046 DBMET01467 | DBMET01461 | |
| 0.025 | 0.055 | 0.045 | Carboxypeptidase B inhibitor | 0.042 0.011 DBMET01468 0.045 0.009 DBMET01459 0.035 0.02 DBMET01460 0.045 0.009 DBMET01466 | DBMET01466 | |
| 0.06 | 0.091 | 0.108 | Ornithine decarboxylase inhibitor | 0.093 0.053 DBMET01468 0.084 0.063 DBMET01461 0.108 0.036 DBMET01459 0.101 0.043 DBMET01460 0.108 0.036 DBMET01466 0.088 0.058 DBMET01467 | DBMET01466 | |
| 0.028 | 0.058 | 0.053 | Tryptophan 5 hydroxylase inhibitor | 0.053 0.005 DBMET01459 0.053 0.005 DBMET01466 0.034 0.029 DBMET01467 | DBMET01466 | |
| 0.019 | 0.051 | 0.025 | Acid ceramidase inhibitor | 0.025 0.019 DBMET01461 | DBMET01461 | |
| 0.039 | 0.073 | 0.052 | Cytokine production stimulant | 0.048 0.034 DBMET01461 0.052 0.023 DBMET01460 0.047 0.037 DBMET01467 | DBMET01460 | |
| 0.044 | 0.079 | 0.08 | Acetylcholine M5 receptor agonist | 0.08 0.034 DBMET01461 0.071 0.043 DBMET01467 | DBMET01461 | |
| 0.019 | 0.055 | 0.055 | Lysophosphatidic acid 2 receptor antagonist | 0.055 0.008 DBMET01460 | DBMET01460 | |
| 0.082 | 0.118 | 0.14 | Amylase inhibitor | 0.127 0.077 DBMET01461 0.115 0.085 DBMET01460 0.14 0.069 DBMET01467 | DBMET01467 | |
| 0.009 | 0.045 | 0.02 | Neurokinin 1 agonist | 0.02 0.014 DBMET01468 | DBMET01468 | |
| 0.037 | 0.073 | 0.102 | Bombesin 2 receptor antagonist | 0.102 0.014 DBMET01468 | DBMET01468 | |
| 0.02 | 0.056 | 0.028 | Epoxide hydrolase 1 inhibitor | 0.028 0.027 DBMET01461 | DBMET01461 | |
| 0.087 | 0.123 | 0.117 | Acetylcholine release stimulant | 0.117 0.054 DBMET01461 0.111 0.063 DBMET01467 | DBMET01461 | |
| 0.018 | 0.055 | 0.033 | Peptide deformylase inhibitor | 0.033 0.019 DBMET01468 | DBMET01468 | |
| 0.014 | 0.052 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.032 0.007 DBMET01460 | DBMET01460 | |
| 0.032 | 0.072 | 0.07 | Glutamate (mGluR4) antagonist | 0.07 0.01 DBMET01459 0.063 0.012 DBMET01460 0.07 0.01 DBMET01466 0.041 0.035 DBMET01467 | DBMET01466 | |
| 0.07 | 0.11 | 0.105 | Falcipain 3 inhibitor | 0.105 0.065 DBMET01461 0.102 0.068 DBMET01467 | DBMET01461 | |
| 0.059 | 0.099 | 0.082 | Interferon agonist | 0.074 0.063 DBMET01461 0.082 0.048 DBMET01460 0.076 0.059 DBMET01467 | DBMET01460 | |
| 0.028 | 0.068 | 0.036 | Potassium channel Kv1.1 blocker | 0.036 0.03 DBMET01461 | DBMET01461 | |
| 0.086 | 0.128 | 0.183 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 DBMET01468 0.116 0.075 DBMET01461 0.183 0.032 DBMET01460 0.122 0.069 DBMET01467 | DBMET01460 | |
| 0.035 | 0.079 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 DBMET01461 0.046 0.039 DBMET01467 | DBMET01461 | |
| 0.003 | 0.048 | 0.011 | Carboxypeptidase B2 inhibitor | 0.011 0.008 DBMET01459 0.011 0.008 DBMET01466 | DBMET01466 | |
| 0.036 | 0.081 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.037 DBMET01461 0.048 0.041 DBMET01467 | DBMET01461 | |
| 0.039 | 0.084 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.043 DBMET01461 0.049 0.045 DBMET01467 | DBMET01461 | |
| 0.069 | 0.115 | 0.217 | Expectorant | 0.217 0.017 DBMET01468 0.089 0.083 DBMET01461 0.135 0.042 DBMET01459 0.131 0.044 DBMET01460 0.135 0.042 DBMET01466 0.095 0.075 DBMET01467 | DBMET01468 | |
| 0.112 | 0.159 | 0.134 | Pregnane X receptor agonist | 0.134 0.089 DBMET01461 0.133 0.091 DBMET01467 | DBMET01461 | |
| 0.044 | 0.092 | 0.063 | 5 Hydroxytryptamine 3 agonist | 0.063 0.045 DBMET01461 0.059 0.05 DBMET01467 | DBMET01461 | |
| 0.027 | 0.076 | 0.119 | Carbonic anhydrase VB inhibitor | 0.115 0.013 DBMET01461 0.066 0.03 DBMET01460 0.078 0.023 DBMET01466 0.119 0.013 DBMET01467 | DBMET01467 | |
| 0.028 | 0.077 | 0.043 | Dihydroorotase inhibitor | 0.043 0.034 DBMET01460 | DBMET01460 | |
| 0.057 | 0.106 | 0.076 | Carbonic anhydrase VI inhibitor | 0.073 0.067 DBMET01461 0.076 0.062 DBMET01467 | DBMET01467 | |
| 0.045 | 0.096 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.061 0.044 DBMET01461 0.068 0.031 DBMET01460 0.057 0.053 DBMET01467 | DBMET01460 | |
| 0.119 | 0.17 | 0.159 | 3C-like protease (Human coronavirus) inhibitor | 0.159 0.087 DBMET01461 0.153 0.096 DBMET01467 | DBMET01461 | |
| 0.048 | 0.099 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 DBMET01460 0.069 0.063 DBMET01467 | DBMET01460 | |
| 0.006 | 0.059 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET01468 | DBMET01468 | |
| 0.145 | 0.198 | 0.217 | 5 Hydroxytryptamine 1E antagonist | 0.217 0.112 DBMET01461 0.205 0.126 DBMET01467 | DBMET01461 | |
| 0.037 | 0.091 | 0.049 | Heparanase inhibitor | 0.049 0.048 DBMET01460 | DBMET01460 | |
| 0.055 | 0.111 | 0.064 | MDM2 inhibitor | 0.063 0.061 DBMET01461 0.064 0.058 DBMET01467 | DBMET01467 | |
| 0.031 | 0.087 | 0.061 | Glutamate (mGluR group III) antagonist | 0.061 0.013 DBMET01459 0.06 0.013 DBMET01460 0.061 0.013 DBMET01466 | DBMET01466 | |
| 0.025 | 0.085 | 0.061 | AMPA 4 receptor antagonist | 0.061 0.01 DBMET01468 0.05 0.015 DBMET01459 0.046 0.019 DBMET01460 0.05 0.015 DBMET01466 | DBMET01468 | |
| 0.089 | 0.149 | 0.149 | Protein kinase stimulant | 0.109 0.107 DBMET01461 0.149 0.069 DBMET01460 0.114 0.099 DBMET01467 | DBMET01460 | |
| 0.025 | 0.086 | 0.069 | Fructose-1,6-bisphosphatase inhibitor | 0.069 0.013 DBMET01460 | DBMET01460 | |
| 0.073 | 0.135 | 0.159 | Alkylator | 0.123 0.065 DBMET01468 0.113 0.075 DBMET01459 0.116 0.072 DBMET01460 0.159 0.042 DBMET01466 | DBMET01466 | |
| 0.053 | 0.115 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.055 DBMET01461 0.07 0.064 DBMET01467 | DBMET01461 | |
| 0.091 | 0.154 | 0.168 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.091 DBMET01461 0.168 0.02 DBMET01460 0.114 0.084 DBMET01467 | DBMET01460 | |
| 0.023 | 0.087 | 0.094 | Antimetabolite | 0.094 0.017 DBMET01468 0.042 0.038 DBMET01459 0.049 0.032 DBMET01460 0.042 0.038 DBMET01466 | DBMET01468 | |
| 0.033 | 0.098 | 0.058 | HCV NS3/NS4A protease inhibitor | 0.058 0.022 DBMET01468 0.049 0.034 DBMET01460 | DBMET01468 | |
| 0.022 | 0.088 | 0.145 | Ribonucleoside-diphosphate reductase inhibitor | 0.145 0.012 DBMET01468 0.053 0.039 DBMET01459 0.048 0.042 DBMET01460 0.053 0.039 DBMET01466 | DBMET01468 | |
| 0.006 | 0.071 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET01468 | DBMET01468 | |
| 0.021 | 0.088 | 0.141 | Ribonucleotide reductase inhibitor | 0.141 0.013 DBMET01468 0.054 0.04 DBMET01459 0.052 0.041 DBMET01460 0.054 0.04 DBMET01466 | DBMET01468 | |
| 0.011 | 0.078 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.014 DBMET01460 | DBMET01460 | |
| 0.041 | 0.109 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.047 DBMET01461 0.067 0.031 DBMET01460 0.055 0.054 DBMET01467 | DBMET01460 | |
| 0.036 | 0.104 | 0.122 | Sphingosine 1-phosphate receptor 4 agonist | 0.068 0.046 DBMET01459 0.122 0.016 DBMET01460 0.068 0.046 DBMET01466 0.059 0.056 DBMET01467 | DBMET01460 | |
| 0.047 | 0.116 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.055 DBMET01468 | DBMET01468 | |
| 0.021 | 0.091 | 0.041 | Glutamate (mGluR4) agonist | 0.037 0.019 DBMET01459 0.041 0.015 DBMET01460 0.037 0.019 DBMET01466 | DBMET01460 | |
| 0.035 | 0.106 | 0.062 | CD45 antagonist | 0.062 0.02 DBMET01468 0.055 0.027 DBMET01460 | DBMET01468 | |
| 0.058 | 0.129 | 0.105 | Alcohol dehydrogenase inhibitor | 0.098 0.055 DBMET01468 0.081 0.079 DBMET01461 0.081 0.078 DBMET01459 0.105 0.047 DBMET01460 0.081 0.078 DBMET01466 0.085 0.071 DBMET01467 | DBMET01460 | |
| 0.038 | 0.111 | 0.11 | Carbonic anhydrase VA inhibitor | 0.108 0.022 DBMET01461 0.069 0.047 DBMET01460 0.088 0.031 DBMET01466 0.11 0.021 DBMET01467 | DBMET01467 | |
| 0.022 | 0.097 | 0.076 | Thymidylate synthase inhibitor | 0.076 0.009 DBMET01468 0.059 0.018 DBMET01461 0.065 0.014 DBMET01459 0.055 0.021 DBMET01460 | DBMET01468 | |
| 0.012 | 0.089 | 0.052 | Kainate receptor 2 antagonist | 0.052 0.015 DBMET01459 0.045 0.019 DBMET01460 0.052 0.015 DBMET01466 | DBMET01466 | |
| 0.056 | 0.133 | 0.325 | Glutathione S-transferase inhibitor | 0.325 0.003 DBMET01468 0.077 0.066 DBMET01459 0.086 0.052 DBMET01460 0.077 0.066 DBMET01466 | DBMET01468 | |
| 0.038 | 0.118 | 0.075 | Carbonic anhydrase XIII inhibitor | 0.075 0.054 DBMET01460 | DBMET01460 | |
| 0.033 | 0.114 | 0.118 | Carbonic anhydrase V inhibitor | 0.114 0.023 DBMET01461 0.072 0.041 DBMET01460 0.087 0.032 DBMET01466 0.118 0.022 DBMET01467 | DBMET01467 | |
| 0.032 | 0.115 | 0.052 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.05 DBMET01460 | DBMET01460 | |
| 0.004 | 0.088 | 0.027 | Kainate receptor 1 antagonist | 0.027 0.012 DBMET01459 0.027 0.012 DBMET01466 | DBMET01466 | |
| 0.034 | 0.118 | 0.064 | Botulinum neurotoxin type A inhibitor | 0.064 0.032 DBMET01468 | DBMET01468 | |
| 0.074 | 0.16 | 0.099 | TRPA1 agonist | 0.099 0.089 DBMET01461 0.099 0.09 DBMET01467 | DBMET01467 | |
| 0.028 | 0.114 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 DBMET01460 | DBMET01460 | |
| 0.026 | 0.12 | 0.057 | GABA B receptor antagonist | 0.057 0.014 DBMET01460 | DBMET01460 | |
| 0.038 | 0.133 | 0.084 | Cathepsin G inhibitor | 0.066 0.059 DBMET01468 0.084 0.041 DBMET01460 | DBMET01460 | |
| 0.084 | 0.181 | 0.157 | Cell wall synthesis inhibitor | 0.124 0.094 DBMET01468 0.115 0.106 DBMET01461 0.157 0.06 DBMET01460 0.121 0.098 DBMET01467 | DBMET01460 | |
| 0.023 | 0.121 | 0.067 | Glutamate (mGluR group III) agonist | 0.054 0.021 DBMET01459 0.067 0.016 DBMET01460 0.054 0.021 DBMET01466 | DBMET01460 | |
| 0.029 | 0.129 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.02 DBMET01460 | DBMET01460 | |
| 0.086 | 0.193 | 0.197 | Hexokinase inhibitor | 0.197 0.037 DBMET01460 0.126 0.11 DBMET01467 | DBMET01460 | |
| 0.02 | 0.127 | 0.05 | Carbonic anhydrase XIV inhibitor | 0.05 0.033 DBMET01460 | DBMET01460 | |
| 0.009 | 0.117 | 0.043 | AMPA 3 receptor antagonist | 0.043 0.012 DBMET01468 0.025 0.024 DBMET01460 | DBMET01468 | |
| 0.08 | 0.189 | 0.144 | Transcription factor STAT6 inhibitor | 0.144 0.028 DBMET01460 | DBMET01460 | |
| 0.086 | 0.197 | 0.117 | DNA repair enzyme inhibitor | 0.117 0.078 DBMET01460 | DBMET01460 | |
| 0.019 | 0.131 | 0.052 | NMDA receptor subunit 3B antagonist | 0.052 0.023 DBMET01460 | DBMET01460 | |
| 0.017 | 0.135 | 0.048 | Metalloproteinase-3 inhibitor | 0.048 0.035 DBMET01468 | DBMET01468 | |
| 0.011 | 0.129 | 0.039 | Calcium-sensing receptor agonist | 0.039 0.008 DBMET01468 | DBMET01468 | |
| 0.045 | 0.164 | 0.097 | Urease inhibitor | 0.097 0.071 DBMET01460 | DBMET01460 | |
| 0.057 | 0.177 | 0.149 | Adenylate cyclase inhibitor | 0.149 0.046 DBMET01460 | DBMET01460 | |
| 0.01 | 0.135 | 0.062 | Kainate receptor antagonist | 0.062 0.015 DBMET01468 0.05 0.022 DBMET01459 0.041 0.028 DBMET01460 0.05 0.022 DBMET01466 | DBMET01468 | |
| 0.013 | 0.138 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET01460 | DBMET01460 | |
| 0.136 | 0.266 | 0.214 | Vasodilator, coronary | 0.211 0.172 DBMET01461 0.213 0.17 DBMET01460 0.214 0.17 DBMET01467 | DBMET01467 | |
| 0.004 | 0.138 | 0.055 | AMPA 1 receptor antagonist | 0.055 0.01 DBMET01468 | DBMET01468 | |
| 0.016 | 0.153 | 0.074 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01468 0.074 0.029 DBMET01460 | DBMET01460 | |
| 0.021 | 0.168 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.036 DBMET01468 | DBMET01468 | |
| 0.016 | 0.163 | 0.107 | Neutrophil collagenase inhibitor | 0.107 0.02 DBMET01468 0.057 0.055 DBMET01460 | DBMET01468 | |
| 0.011 | 0.158 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.03 DBMET01460 | DBMET01460 | |
| 0.014 | 0.165 | 0.042 | Factor XIIIa inhibitor | 0.042 0.021 DBMET01468 | DBMET01468 | |
| 0.128 | 0.281 | 0.183 | Neuropeptide Y2 antagonist | 0.183 0.152 DBMET01468 | DBMET01468 | |
| 0.082 | 0.236 | 0.248 | Insulin sensitizer | 0.248 0.036 DBMET01468 0.163 0.116 DBMET01459 0.163 0.116 DBMET01466 | DBMET01468 | |
| 0.013 | 0.169 | 0.045 | Matrix metalloproteinase 1 inhibitor | 0.045 0.042 DBMET01468 | DBMET01468 | |
| 0.012 | 0.17 | 0.064 | NMDA 2A receptor antagonist | 0.064 0.027 DBMET01468 0.051 0.037 DBMET01460 | DBMET01468 | |
| 0.01 | 0.167 | 0.195 | Carbonic anhydrase VII inhibitor | 0.195 0.005 DBMET01461 0.097 0.01 DBMET01459 0.046 0.033 DBMET01467 | DBMET01461 | |
| 0.086 | 0.25 | 0.524 | Immunostimulant | 0.524 0.026 DBMET01468 0.225 0.107 DBMET01461 0.311 0.076 DBMET01459 0.224 0.107 DBMET01460 0.409 0.047 DBMET01466 0.237 0.102 DBMET01467 | DBMET01468 | |
| 0.051 | 0.216 | 0.125 | Proteasome inhibitor | 0.125 0.061 DBMET01468 | DBMET01468 | |
| 0.013 | 0.179 | 0.242 | Glycine transporter 2 inhibitor | 0.242 0.004 DBMET01468 | DBMET01468 | |
| 0.124 | 0.291 | 0.213 | Vasodilator, peripheral | 0.213 0.161 DBMET01460 0.194 0.183 DBMET01467 | DBMET01460 | |
| 0.05 | 0.218 | 0.112 | Nav1.6 sodium channel blocker | 0.112 0.109 DBMET01461 | DBMET01461 | |
| 0.015 | 0.192 | 0.041 | Sphingosine 1-phosphate receptor agonist | 0.041 0.036 DBMET01460 | DBMET01460 | |
| 0.029 | 0.221 | 0.073 | Metalloproteinase-9 inhibitor | 0.073 0.051 DBMET01468 | DBMET01468 | |
| 0.02 | 0.212 | 0.077 | Matrix metalloproteinase inhibitor | 0.077 0.039 DBMET01468 | DBMET01468 | |
| 0.047 | 0.248 | 0.133 | Caspase 3 inhibitor | 0.133 0.043 DBMET01468 | DBMET01468 | |
| 0.025 | 0.227 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 DBMET01460 | DBMET01460 | |
| 0.122 | 0.327 | 0.319 | Transcription factor inhibitor | 0.319 0.145 DBMET01467 | DBMET01467 | |
| 0.027 | 0.233 | 0.099 | Metalloproteinase-2 inhibitor | 0.099 0.039 DBMET01468 | DBMET01468 | |
| 0.04 | 0.247 | 0.091 | Interleukin 1 beta converting enzyme inhibitor | 0.091 0.07 DBMET01468 | DBMET01468 | |
| 0.045 | 0.254 | 0.113 | Alkaline phosphatase inhibitor | 0.113 0.096 DBMET01460 | DBMET01460 | |
| 0.009 | 0.22 | 0.04 | Purinergic P2Y antagonist | 0.04 0.036 DBMET01460 | DBMET01460 | |
| 0.006 | 0.218 | 0.156 | Carbonic anhydrase I inhibitor | 0.156 0.009 DBMET01461 0.111 0.016 DBMET01459 | DBMET01461 | |
| 0.006 | 0.226 | 0.152 | Carbonic anhydrase II inhibitor | 0.152 0.01 DBMET01461 0.101 0.018 DBMET01459 | DBMET01461 | |
| 0.055 | 0.275 | 0.165 | Pyruvate kinase inhibitor | 0.165 0.103 DBMET01460 | DBMET01460 | |
| 0.063 | 0.288 | 0.212 | Thiol protease inhibitor | 0.212 0.035 DBMET01468 | DBMET01468 | |
| 0.005 | 0.233 | 0.185 | Carbonic anhydrase IX inhibitor | 0.185 0.009 DBMET01461 0.116 0.017 DBMET01459 | DBMET01461 | |
| 0.001 | 0.23 | 0.035 | Mannitol 2-dehydrogenase inhibitor | 0.035 0.001 DBMET01460 | DBMET01460 | |
| 0.056 | 0.288 | 0.202 | Phospholipase A2 inhibitor | 0.202 0.041 DBMET01468 0.12 0.117 DBMET01460 | DBMET01468 | |
| 0.101 | 0.345 | 0.307 | Antithrombotic | 0.307 0.084 DBMET01468 0.221 0.153 DBMET01460 | DBMET01468 | |
| 0.042 | 0.286 | 0.173 | Psychostimulant | 0.173 0.098 DBMET01460 | DBMET01460 | |
| 0.026 | 0.272 | 0.094 | Inducible nitric-oxide synthase inhibitor | 0.094 0.043 DBMET01459 0.094 0.043 DBMET01466 | DBMET01466 | |
| 0.007 | 0.255 | 0.198 | Carbonic anhydrase inhibitor | 0.186 0.011 DBMET01461 0.198 0.01 DBMET01459 | DBMET01459 | |
| 0.076 | 0.331 | 0.147 | Focal adhesion kinase 2 inhibitor | 0.147 0.136 DBMET01460 | DBMET01460 | |
| 0.03 | 0.302 | 0.137 | Nitric-oxide synthase inhibitor | 0.086 0.085 DBMET01468 0.137 0.028 DBMET01459 0.137 0.028 DBMET01466 | DBMET01466 | |
| 0.065 | 0.343 | 0.203 | Calpain inhibitor | 0.203 0.111 DBMET01468 | DBMET01468 | |
| 0.028 | 0.314 | 0.074 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.059 DBMET01460 | DBMET01460 | |
| 0.059 | 0.398 | 0.73 | DNA damaging | 0.345 0.042 DBMET01461 0.73 0.004 DBMET01459 0.214 0.105 DBMET01466 | DBMET01459 | |
| 0.066 | 0.42 | 0.239 | Transcription factor STAT3 inhibitor | 0.239 0.093 DBMET01460 | DBMET01460 | |
| 0.05 | 0.505 | 0.236 | Transcription factor STAT inhibitor | 0.236 0.097 DBMET01460 | DBMET01460 | |
| 0.033 | 0.579 | 0.222 | 15-Lipoxygenase inhibitor | 0.213 0.199 DBMET01461 0.222 0.19 DBMET01467 | DBMET01467 | |
| 0.022 | 0.703 | 0.446 | Antibacterial | 0.278 0.152 DBMET01461 0.446 0.058 DBMET01459 0.354 0.1 DBMET01460 | DBMET01459 | |
| 0.005 | 0.841 | 0.648 | Tubulin antagonist | 0.648 0.005 DBMET01461 0.536 0.006 DBMET01466 0.563 0.005 DBMET01467 | DBMET01461 | |
| 0.004 | 0.925 | 0.91 | Acetyl-CoA transferase inhibitor | 0.91 0.001 DBMET01466 | DBMET01466 | |
| 0.001 | 0.97 | 0.034 | Aminopeptidase P inhibitor | 0.034 0.008 DBMET01468 0.022 0.018 DBMET01459 0.022 0.018 DBMET01466 | DBMET01468 | |
| 0.016 | 0.997 | 0.326 | Peptidyltransferase inhibitor | 0.326 0.017 DBMET01468 0.243 0.056 DBMET01459 0.243 0.056 DBMET01466 | DBMET01468 | |
| 0.004 | 0.994 | 0.071 | Glutamate (mGluR8) antagonist | 0.055 0.006 DBMET01468 0.071 0.004 DBMET01459 0.071 0.004 DBMET01466 | DBMET01466 | |
| 0.007 | 0.998 | 0.408 | Interleukin 2 agonist | 0.393 0.029 DBMET01468 0.408 0.025 DBMET01459 0.408 0.025 DBMET01466 | DBMET01466 | |
| 0.004 | 0.996 | 0.089 | Adenine nucleotide translocase inhibitor | 0.089 0.006 DBMET01468 0.052 0.051 DBMET01459 0.052 0.051 DBMET01466 | DBMET01468 | |
| 0.004 | 0.998 | 0.45 | Sodium/bile acid cotransporter inhibitor | 0.45 0.007 DBMET01468 | DBMET01468 | |
| 0.003 | 0.996 | 0.617 | Antimitotic | 0.312 0.041 DBMET01461 0.617 0.006 DBMET01466 0.268 0.053 DBMET01467 | DBMET01466 | |
| 0.001 | 0.995 | 0.115 | Purinergic P2X agonist | 0.115 0.003 DBMET01460 | DBMET01460 | |
| 0.003 | 0.999 | 0.4 | Growth hormone agonist | 0.4 0.016 DBMET01468 0.272 0.038 DBMET01459 0.272 0.038 DBMET01466 | DBMET01468 | |
| 0.002 | 0.998 | 0.042 | Integrin alpha1beta1 antagonist | 0.038 0.027 DBMET01468 0.042 0.017 DBMET01459 0.042 0.017 DBMET01466 | DBMET01466 | |
| 0.002 | 0.998 | 0.115 | Vanilloid 2 antagonist | 0.115 0.004 DBMET01459 0.115 0.004 DBMET01466 | DBMET01466 | |
| 0.002 | 0.998 | 0.315 | DNA polymerase I inhibitor | 0.315 0.01 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.111 | Somatostatin 1 agonist | 0.111 0.027 DBMET01468 | DBMET01468 | |
| 0 | 0.997 | 0.007 | Purinergic P2Y4 agonist | 0.007 0.002 DBMET01460 | DBMET01460 | |
| 0.002 | 0.999 | 0.172 | Factor V inhibitor | 0.172 0.011 DBMET01468 0.107 0.056 DBMET01459 0.107 0.056 DBMET01466 | DBMET01468 | |
| 0.002 | 0.999 | 0.164 | Folate antagonist | 0.164 0.018 DBMET01468 0.136 0.028 DBMET01459 0.136 0.028 DBMET01466 | DBMET01468 | |
| 0 | 0.997 | 0.039 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.013 DBMET01468 0.039 0.004 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.062 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.029 DBMET01468 0.062 0.003 DBMET01460 | DBMET01460 | |
| 0 | 0.998 | 0.041 | Caspase 2 inhibitor | 0.041 0.015 DBMET01468 0.027 0.026 DBMET01459 0.027 0.026 DBMET01466 | DBMET01468 | |
| 0 | 0.997 | 0.047 | Purinergic P2Y agonist | 0.047 0.003 DBMET01460 | DBMET01460 | |
| 0.002 | 0.999 | 0.112 | Transcription factor NF kappa B stimulant | 0.112 0.029 DBMET01468 | DBMET01468 | |
| 0.001 | 0.999 | 0.071 | Caspase 9 inhibitor | 0.071 0.031 DBMET01468 | DBMET01468 | |
| 0 | 0.998 | 0.056 | Purinergic receptor agonist | 0.056 0.003 DBMET01460 | DBMET01460 | |
| 0 | 0.998 | 0.056 | Purinergic P2 agonist | 0.056 0.003 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.065 | Cholecystokinin B agonist | 0.065 0.01 DBMET01468 | DBMET01468 | |
| 0 | 0.998 | 0.017 | Carbonic anhydrase IV stimulant | 0.017 0.008 DBMET01468 | DBMET01468 | |
| 0 | 0.998 | 0.059 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.022 0.006 DBMET01468 0.059 0.004 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.111 | Erythropoietin receptor agonist | 0.111 0.009 DBMET01468 | DBMET01468 | |
| 0.001 | 0.998 | 0.413 | Angiogenesis stimulant | 0.413 0.02 DBMET01468 0.254 0.068 DBMET01459 0.254 0.068 DBMET01466 | DBMET01468 | |
| 0 | 0.998 | 0.03 | Kainate receptor 4 antagonist | 0.03 0.013 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.081 | Neurotensin receptor antagonist | 0.081 0.018 DBMET01468 0.044 0.032 DBMET01459 0.044 0.032 DBMET01466 | DBMET01468 | |
| 0.001 | 0.998 | 0.095 | Purinergic P2Y2 antagonist | 0.095 0.004 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.158 | Aminopeptidase N inhibitor | 0.08 0.017 DBMET01468 0.158 0.005 DBMET01460 | DBMET01460 | |
| 0.001 | 0.998 | 0.176 | Aminopeptidase microsomal inhibitor | 0.099 0.018 DBMET01468 0.054 0.044 DBMET01459 0.176 0.005 DBMET01460 0.054 0.044 DBMET01466 | DBMET01460 | |
| 0 | 0.998 | 0.052 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.052 0.004 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.887 | Estrogen receptor beta antagonist | 0.887 0.002 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.021 | Vitamin D receptor antagonist | 0.021 0.018 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.114 | Toll-Like receptor 4 antagonist | 0.114 0.051 DBMET01460 | DBMET01460 | |
| 0 | 0.998 | 0.083 | Complement C3a chemotactic receptor antagonist | 0.083 0.013 DBMET01468 0.078 0.015 DBMET01459 0.078 0.015 DBMET01466 | DBMET01468 | |
| 0 | 0.998 | 0.053 | Collagenase inhibitor | 0.053 0.025 DBMET01468 | DBMET01468 | |
| 0.001 | 0.999 | 0.065 | Cathepsin E inhibitor | 0.065 0.034 DBMET01468 | DBMET01468 | |
| 0 | 0.998 | 0.071 | Carbonic anhydrase I stimulant | 0.071 0.009 DBMET01468 0.039 0.025 DBMET01459 0.039 0.025 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.029 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.01 DBMET01468 0.029 0.004 DBMET01459 0.029 0.004 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.092 | Angiotensin-converting enzyme inhibitor | 0.092 0.01 DBMET01468 0.056 0.036 DBMET01459 0.053 0.04 DBMET01460 0.056 0.036 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.056 | Growth hormone release inhibitor | 0.056 0.018 DBMET01468 | DBMET01468 | |
| 0.001 | 0.999 | 0.072 | Carbonic anhydrase II stimulant | 0.072 0.013 DBMET01468 0.052 0.036 DBMET01459 0.052 0.036 DBMET01466 | DBMET01468 | |
| 0.001 | 0.999 | 0.064 | Maillard reaction inhibitor | 0.064 0.032 DBMET01459 0.064 0.032 DBMET01466 | DBMET01466 | |
| 0.001 | 0.999 | 0.86 | Estrogen antagonist | 0.86 0.002 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.16 | Sphingosine 1-phosphate receptor 2 agonist | 0.16 0.021 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.088 | Sphingosine 1-phosphate receptor 5 agonist | 0.088 0.01 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.044 | Bradykinin B2 receptor agonist | 0.044 0.01 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.136 | Squalene synthetase inhibitor | 0.136 0.004 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.024 | Integrin beta7 antagonist | 0.024 0.012 DBMET01459 0.024 0.012 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.062 | Integrin alpha5beta1 antagonist | 0.062 0.011 DBMET01468 0.038 0.032 DBMET01459 0.038 0.032 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.039 | AMPA 2 receptor antagonist | 0.039 0.015 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.033 | Neutral endopeptidase inhibitor | 0.033 0.011 DBMET01468 0.026 0.013 DBMET01460 | DBMET01468 | |
| 0 | 0.999 | 0.052 | VLA-4 antagonist | 0.023 0.02 DBMET01468 0.052 0.012 DBMET01459 0.052 0.012 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.019 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.179 | M17 leucyl aminopeptidase inhibitor | 0.179 0.041 DBMET01460 | DBMET01460 | |
| 0.001 | 0.999 | 0.256 | Chelator | 0.256 0.015 DBMET01468 | DBMET01468 | |
| 0.001 | 0.999 | 0.279 | Hepatoprotectant | 0.279 0.036 DBMET01468 0.143 0.117 DBMET01459 0.143 0.117 DBMET01466 | DBMET01468 | |
| 0.001 | 0.999 | 0.082 | Vanilloid agonist | 0.082 0.066 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.03 | Adenosine A1 receptor agonist | 0.03 0.012 DBMET01461 0.03 0.012 DBMET01467 | DBMET01467 | |
| 0 | 0.999 | 0.134 | Sphingosine 1-phosphate receptor 3 agonist | 0.134 0.005 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.051 | Macrophage elastase inhibitor | 0.051 0.024 DBMET01468 | DBMET01468 | |
| 0.001 | 0.999 | 0.312 | Hematopoietic | 0.312 0.005 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.04 | VCAM-1 antagonist | 0.038 0.032 DBMET01468 0.04 0.026 DBMET01459 0.04 0.026 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.04 | VCAM antagonist | 0.038 0.032 DBMET01468 0.04 0.026 DBMET01459 0.04 0.026 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.12 | GP IIb/IIIa receptor antagonist | 0.12 0.014 DBMET01468 0.044 0.037 DBMET01459 0.044 0.037 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.055 | Protocollagen prolyl hydroxylase inhibitor | 0.055 0.005 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.222 | Endothelin-converting enzyme inhibitor | 0.074 0.019 DBMET01468 0.222 0.004 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.114 | Sirtuin 1 inhibitor | 0.114 0.016 DBMET01468 0.068 0.047 DBMET01459 0.068 0.047 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.193 | Purinergic P2X2 antagonist | 0.193 0.005 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.026 | Integrin alpha4beta7 antagonist | 0.026 0.011 DBMET01459 0.026 0.011 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.019 | Vitronectin receptor antagonist | 0.019 0.016 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.136 | Selectin antagonist | 0.136 0.02 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.035 | Purinergic P2Y1 antagonist | 0.035 0.005 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.044 | Toll-Like receptor 4 agonist | 0.044 0.004 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.688 | Antioxidant | 0.285 0.068 DBMET01468 0.688 0.006 DBMET01461 0.477 0.023 DBMET01459 0.375 0.04 DBMET01466 | DBMET01461 | |
| 0 | 0.999 | 0.282 | Lipid peroxidase inhibitor | 0.282 0.021 DBMET01468 0.164 0.059 DBMET01459 0.164 0.059 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.024 | Integrin alpha4 antagonist | 0.024 0.018 DBMET01459 0.024 0.018 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.922 | Free radical scavenger | 0.922 0.003 DBMET01461 0.558 0.011 DBMET01459 0.475 0.019 DBMET01466 0.267 0.062 DBMET01467 | DBMET01461 | |
| 0 | 0.999 | 0.132 | Nav1.4 sodium channel blocker | 0.132 0.043 DBMET01468 0.095 0.084 DBMET01459 0.095 0.084 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.068 | Integrin antagonist | 0.068 0.022 DBMET01468 0.038 0.032 DBMET01459 0.038 0.032 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.184 | Protein-tyrosine phosphatase 1B inhibitor | 0.184 0.034 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.664 | Bone formation stimulant | 0.147 0.061 DBMET01468 0.664 0.003 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.054 | Opioid delta receptor antagonist | 0.054 0.05 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.348 | Aminoacyl-tRNA synthetase inhibitor | 0.143 0.021 DBMET01468 0.333 0.005 DBMET01461 0.152 0.018 DBMET01459 0.348 0.005 DBMET01466 0.324 0.005 DBMET01467 | DBMET01466 | |
| 0 | 0.999 | 0.05 | Cathepsin D inhibitor | 0.05 0.042 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.169 | Autotaxin inhibitor | 0.169 0.006 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.109 | Glucagon-like peptide 1 agonist | 0.109 0.018 DBMET01468 0.058 0.05 DBMET01459 0.058 0.05 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.053 | Neurokinin 2 agonist | 0.053 0.017 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.079 | Neuropeptide agonist | 0.079 0.032 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.386 | Thrombolytic | 0.386 0.013 DBMET01468 0.323 0.02 DBMET01459 0.323 0.02 DBMET01466 | DBMET01468 | |
| 0 | 0.999 | 0.15 | Protein-tyrosine phosphatase inhibitor | 0.15 0.079 DBMET01460 | DBMET01460 | |
| 0 | 0.999 | 0.078 | Beta tubulin antagonist | 0.073 0.033 DBMET01461 0.078 0.03 DBMET01467 | DBMET01467 | |
| 0 | 0.999 | 0.072 | Cell adhesion molecule inhibitor | 0.072 0.066 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.031 | Renin inhibitor | 0.031 0.03 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.138 | Protease inhibitor | 0.138 0.036 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.084 | Leukotriene A4 hydrolase inhibitor | 0.084 0.008 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.042 | AMPA receptor agonist | 0.042 0.015 DBMET01459 0.042 0.015 DBMET01466 | DBMET01466 | |
| 0 | 0.999 | 0.115 | Cell adhesion inhibitor | 0.115 0.069 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.371 | Amyloid beta aggregation inhibitor | 0.175 0.092 DBMET01461 0.371 0.03 DBMET01466 0.205 0.075 DBMET01467 | DBMET01466 | |
| 0 | 0.999 | 0.332 | Apoptosis antagonist | 0.332 0.065 DBMET01468 0.292 0.091 DBMET01459 0.292 0.091 DBMET01466 | DBMET01468 | |
| 0 | 1 | 0.238 | Histone deacetylase SIRT1 inhibitor | 0.238 0.02 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.055 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.051 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.289 | Platelet antagonist | 0.289 0.056 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.028 | Cholecystokinin B antagonist | 0.028 0.023 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.033 | Cholecystokinin A antagonist | 0.033 0.029 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.087 | Chymotrypsin inhibitor | 0.087 0.046 DBMET01468 | DBMET01468 | |
| 0 | 0.999 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.08 | Nitric oxide donor | 0.08 0.022 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.509 | Interleukin antagonist | 0.509 0.019 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.053 | Kallikrein 1 inhibitor | 0.053 0.046 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.051 | Bombesin antagonist | 0.051 0.028 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.059 | Human rhinovirus A protease inhibitor | 0.059 0.035 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.258 | Anticoagulant | 0.258 0.037 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.791 | DNA intercalator | 0.791 0.003 DBMET01461 0.126 0.054 DBMET01459 | DBMET01461 | |
| 0 | 1 | 0.06 | Trypsin inhibitor | 0.06 0.047 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.153 | Histone deacetylase class III inhibitor | 0.153 0.042 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.217 | Immunomodulator | 0.217 0.145 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.117 | Factor XII inhibitor | 0.117 0.025 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.055 | Cathepsin F inhibitor | 0.055 0.008 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.899 | Antiinflammatory | 0.899 0.005 DBMET01460 | DBMET01460 | |
| 0 | 1 | 0.075 | Thrombin inhibitor | 0.075 0.048 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.074 | Cathepsin B inhibitor | 0.074 0.026 DBMET01468 | DBMET01468 | |
| 0 | 1 | 0.083 | Bombesin 1 receptor agonist | 0.083 0.024 DBMET01468 | DBMET01468 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |